Montréal, February 18, 2014 – Charges were laid in relation to a clandestine laboratory that was dismantled in Longueuil by our Clandestine Laboratory Enforcement Team (CLET) last November 20th. Upon investigation, steroids and substances that could have been used to produce over 280,000 counterfeit pills of an erectile dysfunction drug were identified. The clandestine lab was located in a storage facility rented in Longueuil industrial area.
Two searches were conducted and the items seized include:
Pill press - High resolution image
Liquid steroids - High resolution image
Seized material - High resolution image
Steroid pills in jars - High resolution image
The packaging quality of the various products looked deceptively similar to real packaging. The seals and labels led users to believe that the products were reliable and high quality. However, the officers quickly realized that the lab was unsanitary and that the criminals took little precaution or care. It should be noted that using counterfeit products hand-made in clandestine labs is extremely dangerous. Users have no idea what is in these products and this poses a real risk for them. The danger is even greater with injectable products like the liquid steroids found in this clandestine lab. The risks of infection are very high.
Alexandre Beaudry, 23, of the Longueuil area, was arrested. It is believed that the suspect used the storage facility to press counterfeit pills and make steroids. He is scheduled to appear in court in Longueuil on February 20, 2014. He could face charges including possession and production of a controlled substance for the purpose of trafficking under the Controlled Drugs and Substances Act.
The investigation was initiated in August 2013 in collaboration with Canada Border Services Agency (CBSA). The operation was conducted with the assistance of the Service de police de la Ville de Longueuil.
You have information on illicit activity by individuals or groups? Contact the RCMP at 514-939-8300 / 1 800 771-5401 or your local police service.